HighTide Therapeutics (HKSE:02511) FCF Yield % : -12.21 (As of May. 20, 2024)

View and export this data going back to 2023. Start your Free Trial

What is HighTide Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, HighTide Therapeutics's Trailing 12-Month Free Cash Flow is HK$-392.36 Mil, and Market Cap is HK$3,212.17 Mil. Therefore, HighTide Therapeutics's FCF Yield % for today is -12.21%.

The historical rank and industry rank for HighTide Therapeutics's FCF Yield % or its related term are showing as below:

HKSE:02511' s FCF Yield % Range Over the Past 10 Years
Min: -14.95 Med: 0 Max: 0
Current: -12.21

HKSE:02511's FCF Yield % is ranked better than
54.27% of 1557 companies
in the Biotechnology industry
Industry Median: -14.1 vs HKSE:02511: -12.21

HighTide Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

HighTide Therapeutics FCF Yield % Historical Data

The historical data trend for HighTide Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HighTide Therapeutics FCF Yield % Chart

HighTide Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

FCF Yield %

-5.88

HighTide Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	-	-	-	-	-7.04

Competitive Comparison of HighTide Therapeutics's FCF Yield %

For the Biotechnology subindustry, HighTide Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HighTide Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HighTide Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where HighTide Therapeutics's FCF Yield % falls into.

HighTide Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

HighTide Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-392.36	/	6671.43216
	=	-5.88%

HighTide Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-234.878	*	2	/	6671.43216
	=	-7.04%

HighTide Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

HighTide Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of HighTide Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

HighTide Therapeutics (HKSE:02511) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HighTide Therapeutics Inc (HKSE:02511) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ganli Second Road, 18B-102, Zhonghaixin Innovation Industry City, Jihua Neighborhood, Longgang District, Guangdong, Shenzhen, CHN, 518112

Website

https://www.hightidetx.com

HighTide Therapeutics Inc is a biopharmaceutical company specializing in the discovery, development and commercialization of multifunctional, multi-targeted therapies for the treatment of metabolic and digestive diseases. The company has developed a product pipeline of five product candidates in-house, covering nine indications in metabolic and digestive diseases among which, five are at clinical-stage. The Core Product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases.

HighTide Therapeutics (HKSE:02511) Headlines

No Headlines